1. Home
  2. SAGE vs AHG Comparison

SAGE vs AHG Comparison

Compare SAGE & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • AHG
  • Stock Information
  • Founded
  • SAGE 2010
  • AHG 2013
  • Country
  • SAGE United States
  • AHG China
  • Employees
  • SAGE N/A
  • AHG N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • AHG Business Services
  • Sector
  • SAGE Health Care
  • AHG Consumer Discretionary
  • Exchange
  • SAGE Nasdaq
  • AHG Nasdaq
  • Market Cap
  • SAGE 444.1M
  • AHG 518.5M
  • IPO Year
  • SAGE 2014
  • AHG N/A
  • Fundamental
  • Price
  • SAGE $7.50
  • AHG $1.35
  • Analyst Decision
  • SAGE Hold
  • AHG
  • Analyst Count
  • SAGE 20
  • AHG 0
  • Target Price
  • SAGE $10.56
  • AHG N/A
  • AVG Volume (30 Days)
  • SAGE 1.6M
  • AHG 49.2K
  • Earning Date
  • SAGE 04-24-2025
  • AHG 03-14-2025
  • Dividend Yield
  • SAGE N/A
  • AHG N/A
  • EPS Growth
  • SAGE N/A
  • AHG N/A
  • EPS
  • SAGE N/A
  • AHG N/A
  • Revenue
  • SAGE $41,243,000.00
  • AHG $2,414,338.00
  • Revenue This Year
  • SAGE $105.47
  • AHG N/A
  • Revenue Next Year
  • SAGE $67.53
  • AHG N/A
  • P/E Ratio
  • SAGE N/A
  • AHG N/A
  • Revenue Growth
  • SAGE N/A
  • AHG N/A
  • 52 Week Low
  • SAGE $4.62
  • AHG $0.60
  • 52 Week High
  • SAGE $22.18
  • AHG $2.35
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.15
  • AHG 52.97
  • Support Level
  • SAGE $7.07
  • AHG $1.22
  • Resistance Level
  • SAGE $7.64
  • AHG $1.46
  • Average True Range (ATR)
  • SAGE 0.27
  • AHG 0.12
  • MACD
  • SAGE 0.00
  • AHG 0.00
  • Stochastic Oscillator
  • SAGE 78.74
  • AHG 54.17

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: